Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725
Linked as:
Extract
Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725
No longer available (Autolink)
See the full content of this document
This document cites
- Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
- Catalyst Paper Corp. v. North Cowichan (District), (2012) 425 N.R. 22 (SCC)
- Syncrude Canada Ltd. v. Canada (Attorney General), (2014) 461 F.T.R. 53 (FC)
- Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)
- Celgene Corp. v. Canada (Attorney General), [2011] N.R. TBEd. JA.001